- Home
- / Lionco Pharmaceutical Group
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lionco Pharmaceutical Group financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥4.9
2024-10-29
Market Capitalization
¥3.7 B
2024-10-29
Revenue
¥364.7 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 13, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.6B | 1.6B | 987.0M | 725.3M | 275.5M | 184.2M | 364.7M |
| Cost of goods sold | 202.0M | 223.2M | 155.7M | 152.7M | 93.1M | 105.0M | 201.7M |
| Gross profit | 1.4B | 1.4B | 832.0M | 578.0M | 189.8M | 86.8M | 173.2M |
| Gross profit margin, % | 86.2% | 84.3% | 79.7% | 68.9% | 47.1% | 47.5% | |
| Operating expense total | 1.3B | 1.2B | 680.7M | 500.5M | 309.6M | 192.8M | 212.0M |
| Depreciation and amortization | 29.7M | 35.5M | 37.4M | 38.9M | 44.7M | 46.9M | 58.4M |
| EBITDA | 161.3M | 219.1M | 136.0M | 79.1M | (132.6M) | (113.0M) | (53.8M) |
| EBITDA margin, % | 13.6% | 13.8% | 10.9% | -48.1% | -61.3% | -14.8% | |
| EBIT | 189.6M | 224.5M | 182.7M | 60.9M | (180.6M) | (146.7M) | (113.4M) |
| EBIT margin, % | 13.9% | 18.5% | 8.4% | -65.6% | -79.6% | -31.1% | |
| Interest income | 2.9M | 4.5M | 7.6M | 9.3M | 7.1M | 3.3M | 1.3M |
| Interest expense | 2.2M | 13.6M | 11.3M | 15.5M | 5.8M | 3.7M | 27.4M |
| Pre tax profit | 204.2M | 222.9M | 179.3M | 70.5M | (188.8M) | (151.0M) | (127.7M) |
| Income tax expense | 21.5M | 21.3M | 19.2M | 4.6M | 7.1M | 541.0K | 3.0M |
| Net Income | 182.7M | 201.6M | 160.1M | 65.9M | (195.9M) | (151.5M) | (130.8M) |